openPR Logo
Press release

Methicillin Susceptible Staphylococcus Aureus (MSSA) Market Current Trends and Future Aspect Analysis 2014 – 2020

03-14-2018 10:42 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Methicillin Susceptible Staphylococcus Aureus (MSSA) Market

Methicillin-susceptible staphylococcus aureus (MSSA) infections are the infections caused by gram-positive bacterium. Staphylococcus aureus is the common pathogen in the skin, bone, central nervous system, pulmonary and soft tissues. These bacteria produce beta-lactamase which is the major cause of the infection. MSSA infection may lead to the skin allergies, pneumonia and endocarditis.

Methicillin-susceptible staphylococcus aureus market is segmented on the basis of the treatment methods used for treating infections which are as follows:
Semi-synthetic penicillin (intravenous oxacillin, intravenous nafcillin, oral dicloxacilin)
Cephalosporins (oral cephalexin, intravenous cefazolin)
Vancomycin (vanocin)
Linezolid (Zyvox)
Daptomycin (Cubicin)

Semi synthetic penicillin captures the major share of the market followed by the cephalosporins. However Vancomycin is only used when patient is allergic to penicillin. In normal conditions, vancomycin is avoided because the rate of action of these drugs is slow in comparison to others and overuse of vancomycin leads to the development of vancomycin resistant staphylococcus aureus bacteria inside the body. Linezolid and Deptomycin are prescribed by the doctors when the MSSA leads to skin and soft tissue infection and pneumonia in children and adults.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2645

Methicillin-susceptible staphylococcus aureus (MSSA) market is growing at faster pace majorly due to increasing rate of morbidity and mortality of the MSSA infection. Additionally, the extensive research and development activities with respect to the development of the more efficient and less time consuming drugs is also driving the market of methicillin-susceptible staphylococcus aureus. As for instance, a study performed at the John Radcliffe Hospital, Oxford, U.K., shows that MSSA infection has mortality rate of 27%.

Therefore, there is an excessive need to develop novel drugs which could help in treating MSSA infection. Cellcutix Corporation has developed a drug by the name Brilacidin, which acts against the acute bacterial skin and skin structure infection (ABSSSI), caused by the MSSA. This drug is currently under phase II clinical trials and it is expected that this drug will help the methicillin-susceptible staphylococcus market to grow.

The other major drugs which are under clinical trials and are expected to show promising results in forecast period includes LTX-109, IMV-0123, SM-295291, SM-369926, Human Cathelicidin LL-37 and ASN-100. However the side effects such as nausea, constipation, head ache, insomnia, anxiety, dizziness, diarrhea and vomiting, associated with the drugs used for treatment of MSSA infection restrains the methicillin-susceptible staphylococcus aureus market.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2645

Europe leads the methicillin-susceptible staphylococcus aureus market followed by North America majorly due to the high prevalence of MSSA infection in these regions, availability of infrastructure and extensive government support for development of drugs with respect to the MSSA infection. As for instance, National Institute for Allergy and Infectious diseases (NIAID) awarded USD 1.68 million to ImmuVen, Inc. for continuing the development of its therapeutic pipeline of IMV0123 against supper antigens produced by methicillin-susceptible staphylococcus aureus.

IMV0123 is expected to show efficient results against pneumonia and endocarditis leading to the growth of the methicillin-susceptible staphylococcus aureus market. Asia-Pacific region is expected to witness a healthy growth rate majorly due to increasing awareness and government support for research and development activities.

Some of the market players in methicillin-susceptible staphylococcus aureus market include Dainippon Sumitomo Pharma Co., Ltd., Immtech Pharmaceuticals, Inc., Lytix Biopharma AS, PharmaIN Corporation, Cubist Pharmaceuticals, Kenta Biotech AG and Arsanis Biosciences GmbH.

Obtain Report Details @ https://www.transparencymarketresearch.com/mssa-market.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Methicillin Susceptible Staphylococcus Aureus (MSSA) Market Current Trends and Future Aspect Analysis 2014 – 2020 here

News-ID: 977982 • Views:

More Releases from Transparency Market Research

Epithelioma Treatment Market Outlook 2035: Rising Skin Cancer Burden, Breakthrough Immunotherapies, and an 8.8% CAGR Growth Trajectory
Epithelioma Treatment Market Outlook 2035: Rising Skin Cancer Burden, Breakthrou …
The global epithelioma treatment market has entered a decisive growth phase, supported by rising cancer prevalence and rapid therapeutic innovation. In 2024, the market was valued at US$ 5.1 Bn, reflecting the growing demand for advanced diagnostic and therapeutic solutions targeting epithelial-origin tumors. Over the forecast period from 2025 to 2035, the industry is projected to expand at a robust compound annual growth rate (CAGR) of 8.8%, reaching a valuation
Tablet Hardness Testers Market to Reach USD 427.9 Mn by 2036, Driven by Rising Pharmaceutical Quality Standards
Tablet Hardness Testers Market to Reach USD 427.9 Mn by 2036, Driven by Rising P …
The Tablet Hardness Testers Market is a critical part of the pharmaceutical quality-control ecosystem. Tablet hardness testers are used to measure the mechanical strength of tablets to ensure they can withstand handling, packaging, transportation, and storage without breaking, while still dissolving correctly once ingested. As regulatory oversight becomes stricter and pharmaceutical production expands globally, the demand for accurate and reliable hardness testing equipment continues to rise. The global Tablet Hardness Testers
Dental Tourism Market to Reach US$ 87.7 Billion by 2035, Driven by Rising Demand for Affordable Cosmetic Dentistry and Cross-Border Healthcare | Latest Report TMR
Dental Tourism Market to Reach US$ 87.7 Billion by 2035, Driven by Rising Demand …
The global dental tourism market was valued at US$ 11.7 billion in 2024 and is projected to reach an impressive US$ 87.7 billion by 2035, expanding at a robust CAGR of 20.1% from 2025 to 2035. The market's rapid expansion is primarily driven by the rising demand for cost-effective yet premium dental treatments, growing cross-border healthcare accessibility, and continuous advancements in dental technologies that enhance treatment quality and patient outcomes. Access
Physical Therapy Software Market Outlook 2035: Global Market to Expand from US$ 1.3 Bn to US$ 3.4 Bn by 2035 at 9.2% CAGR
Physical Therapy Software Market Outlook 2035: Global Market to Expand from US$ …
The global physical therapy software market is witnessing strong and sustained growth as healthcare systems increasingly adopt digital tools to improve clinical efficiency, patient engagement, and treatment outcomes. Valued at US$ 1.3 billion in 2024, the market is projected to reach US$ 3.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 9.2% from 2025 to 2035. This expansion reflects the growing demand for technology-driven rehabilitation services,

All 5 Releases


More Releases for MSSA

Liquid Sodium Market Have High Growth but May Foresee Even Higher Value| MSSA, I …
The Liquid Sodium market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development
Sodium Metal Market Size to Surpass US$ 229 million by 2027 | MSSA S.A.S., Ameri …
Sodium Metal Market According to the latest market research report, the global sodium metal market is expected to grow at a CAGR of 35.1% during the forecast period (2022-2027). The market is expected to reach a value of US$ 229 million by 2027, up from US$ 184 million in 2021. The growing demand for sodium metal from the chemical and pharmaceutical industries is expected to drive the market growth during the
Sodium Metal Market to reach around US$ 350.3 million by the end of 2024 | Wanji …
Sodium Metal Market The global sodium metal market is projected to reach around US$ 350.3 million by the end of 2024, in terms of revenue, growing at CAGR of 3.3% during the forecast period (2016-2024). Global consumption of sodium metal will grow at a sluggish CAGR of 3.3% through 2024, according to Persistence Market Research's report entitled, "Sodium Metal Market: Global Industry Analysis and Forecast, 2016 - 2024." In 2016, over 98,400 MT sodium
Sodium Metal Market will grow at a sluggish CAGR of 5.1% through 2027|Key Player …
Sodium Metal Market Forecast to 2027 By the end of 2027, the global sodium metal market is anticipated to generate revenues of about US$ 512.1 million, expanding at a CAGR of 5.1%. (2022-2027). The Sodium Metal Market is an increasingly important market that plays a role in many industries. Sodium metal can be used in a variety of ways, including as the primary material for producing sodium hydroxide, a key component of
Sodium Metal Market Generated Opportunities, Future Scope 2022-2028 | Inner Mong …
Synopsis Of The Report A new study titled Sodium Metal Market 2022, published by The Coherent Market Insights, provides information on regional and global markets that is anticipated to increase in value between 2022 and 2028. The extensive research on the global Sodium Metal Market offers important insights into the market's shifting dynamics, value chain analysis, well-known investment hotspots, competitive scenarios, regional landscape, and major segments. It also offers a complete
Sodium Metal Market Covering Competitive Scenario: Wanji Holdings Group Limited, …
Global consumption of sodium metal will grow at a sluggish CAGR of 3.3% through 2024, according to Persistence Market Research’s report entitled, “Sodium Metal Market: Global Industry Analysis and Forecast, 2016 - 2024.” In 2016, over 98,400 MT sodium metal was consumed globally, and it is estimated to surpass 127,400 MT by 2024.  The sluggish demand for sodium metal is attributed to hazardous effects of highly reactive sodium element. Challenges with